Literature DB >> 8833734

The role of insulin-like growth factors in prostate biology.

D M Peehl1, P Cohen, R G Rosenfeld.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8833734

Source DB:  PubMed          Journal:  J Androl        ISSN： 0196-3635


× No keyword cloud information.
  12 in total

Review 1.  Benign prostatic hyperplasia: dietary and metabolic risk factors.

Authors:  H Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-02-02       Impact factor: 2.370

Review 2.  Risk factors for benign prostatic hyperplasia.

Authors:  Steven J Jacobsen
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

3.  Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study.

Authors:  Selçuk Altın; Tunç Ozan; Selçuk İlhan; Nevin İlhan; Rahmi Onur
Journal:  Turk J Urol       Date:  2015-09

Review 4.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

Review 5.  Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity.

Authors:  Anne K Mongiu; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

Review 6.  Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

Authors:  James Beattie; Gordon J Allan; Jennifer D Lochrie; David J Flint
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

7.  Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age.

Authors:  Sung Jin Yim; Young Sam Cho; Kwan Joong Joo
Journal:  Korean J Urol       Date:  2011-06-17

8.  Association of metabolic syndrome and benign prostate enlargement in young korean males.

Authors:  Jee Hoon Jeong; Eun Tak Kim; Dae Kyung Kim
Journal:  Korean J Urol       Date:  2011-11-17

9.  Evidence for the Possible Biological Significance of the igf-1 Gene Alternative Splicing in Prostate Cancer.

Authors:  Anastassios Philippou; Athanasios Armakolas; Michael Koutsilieris
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-20       Impact factor: 5.555

10.  Genetic polymorphisms in IGF-I and IGFBP-3 are associated with prostate cancer in the Chinese population.

Authors:  Jian Qian; Hai Zhou; Jiawei Chen; Qi Ding; Qiang Cao; Chao Qin; Pengfei Shao; Pu Li; Hongzhou Cai; Xiaoxin Meng; Xiaobing Ju; Meilin Wang; Zhengdong Zhang; Jie Li; Lixin Hua; Changjun Yin
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.